Quantcast

Fosamax suit can’t proceed based on ‘sham’ issue (access required)

Published: February 4, 2013

Tags: , , , , ,

Irreconcilable contradictions in expert testimony prevented a product liability plaintiff from establishing that Merck failed to provide adequate warnings with the osteoporosis drug Fosamax, the 2nd Circuit has ruled in affirming judgment.
© Copyright 2013 Lawyers USA. All Rights Reserved.


Comments

You must be logged in to post comments.

Sign-up for alerts

FEATURED PODCAST


Lawyers USA presents Lawyers in Practice

This is the first edition of Lawyers USA's Lawyers in Practice, where we discuss the hot issues facing practicing attorneys and law firms.

In this edition, we discuss how to prevent legal malpractice claims with better communication, with Jim Calloway, director of the Oklahoma Bar Association's Management Assistance Program, and Dan Pinnington, vice-president of Claims Prevention and Stakeholder Relations at LawPRO, a professional liability carrier based in Toronto, Canada.

Visit the Legal Malpractice Monitor to listen to the podcast.

Click here to download the podcast.